NCT06550193 Augmented Reality/Virtual Reality (AR/VR) for Ultrasound-guided Medical Procedures
| NCT ID | NCT06550193 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Augmented Reality |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-09-30 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-09-30 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study seeks to assess the efficacy of incorporating augmented reality (AR) or virtual reality (VR) technology into ultrasound-guided medical procedures such as regional anesthesia and line placement. By utilizing AR/VR devices, the investigators will improve the ergonomics when using ultrasound to guide procedures. The aims are to enhance visualization of anatomical structures and improve procedural accuracy for clinicians. The study aims to evaluate the feasibility, and effectiveness of integrating AR/VR technology into ultrasound-guided procedures, with the ultimate goal of improving patient outcomes.
Eligibility Criteria
Inclusion Criteria: * adult patients presenting for ultrasound-guided procedures, with ASA physical status I, II, or III. Exclusion Criteria: * pregnancy * incarceration * BMI \>35
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06550193 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Augmented Reality. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06550193 currently recruiting?
Yes, NCT06550193 is actively recruiting participants. Contact the research team at hornj@stanford.edu for enrollment information.
Where is the NCT06550193 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT06550193 clinical trial?
NCT06550193 is sponsored by Stanford University. The trial plans to enroll 100 participants.